Viewing Study NCT03422094


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-01-04 @ 7:20 AM
Study NCT ID: NCT03422094
Status: TERMINATED
Last Update Posted: 2021-10-27
First Post: 2018-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Sponsor: Washington University School of Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 201804195
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View